![GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November](https://ala.associates/wp-content/uploads/2022/04/GamaMabs_Logo.png)
![GamaMabs Pharma to present new data on GM102 at two upcoming scientific conferences in November](https://ala.associates/wp-content/uploads/2022/04/GamaMabs_Logo.png)
![Nosopharm appoints Dr Sarah Gould as chief development officer](https://ala.associates/wp-content/uploads/2022/04/2016-05-27_Sarah-GOULD_2_HD-e1542013944733-500x250-1.jpg)
Nosopharm appoints Dr Sarah Gould as chief development officer
![Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes](https://ala.associates/wp-content/uploads/2022/04/IMCYSEBLlogo-500x250-1.jpg)
Imcyse successfully completes patient enrollment in first-in-human Phase 1b study in type 1 diabetes
![Bionure appoints Dr. Laurent Nguyen as CEO](https://ala.associates/wp-content/uploads/2022/04/ngcd-laurent-0012-472x250-1.jpeg)
Bionure appoints Dr. Laurent Nguyen as CEO
![Minoryx Therapeutics raises €21.3M in Series B funding round](https://ala.associates/wp-content/uploads/2022/04/Photo-Marc-Martinell-2015-1-500x250-1.jpg)
Minoryx Therapeutics raises €21.3M in Series B funding round
![GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102](https://ala.associates/wp-content/uploads/2022/04/SDegove-1-e1536919432418-500x250-1.jpg)
GamaMabs Pharma starts a phase 2 study of monoclonal antibody GM102
![Minoryx announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)](https://ala.associates/wp-content/uploads/2017/01/Uwe-Meya2-1080x675.jpg)
Minoryx announces dosing of first US patient in phase 2/3 clinical study of MIN-102 (ADVANCE)
![Inoviem Scientific enters into service-based partnership with XoNovo](https://ala.associates/wp-content/uploads/2022/04/inoviem-xonovo-e1536064791495-500x250-1.png)
Inoviem Scientific enters into service-based partnership with XoNovo
![Univercells raises EUR 16 million in Series B financing round led by Global Health Investment Fund](https://ala.associates/wp-content/uploads/2016/12/Hugues-Bultot-e1513334784884-1080x675.jpg)
Univercells raises EUR 16 million in Series B financing round led by Global Health Investment Fund
![Yposkesi appoints Dr. Fraser Wright as senior advisor](https://ala.associates/wp-content/uploads/2022/04/J-Fraser-Wright-picture-346x250-1.jpg)